The updated regulations for establishing regional headquarters in Shanghai offer multinational companies greater clarity on eligibility, approval processes and specific advantages
China launches a “Two-Invoice System” to simplify the drug distribution chain and reduce prices and corruption in the healthcare sector. The new policy may bring substantial compliance and business model challenges for pharmaceutical companies